BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35933554)

  • 21. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA; Millar WT; Visser AG; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple method of obtaining equivalent doses for use in HDR brachytherapy.
    Nag S; Gupta N
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):507-13. PubMed ID: 10661360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intratumor heterogeneity on BED for hypofractionated dose regimens.
    Kuperman VY
    Med Phys; 2019 Oct; 46(10):4690-4698. PubMed ID: 31257607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Tumor Control and Skin Damage in a Mouse Model after Ultra-High Dose Rate Irradiation and Conventional Irradiation.
    Duval KEA; Aulwes E; Zhang R; Rahman M; Ashraf MR; Sloop A; Sunnerberg J; Williams BB; Cao X; Bruza P; Kheirollah A; Tavakkoli A; Jarvis LA; Schaner PE; Swartz HM; Gladstone DJ; Pogue BW; Hoopes PJ
    Radiat Res; 2023 Sep; 200(3):223-231. PubMed ID: 37590482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionation: what does it mean for prostate cancer treatment?
    Liao Y; Joiner M; Huang Y; Burmeister J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):260-8. PubMed ID: 19879698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
    Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
    Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
    Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-Fraction Stereotactic Radiosurgery With Different Gross Tumor Doses and Inhomogeneities for Brain Metastasis of >10 cc: Treatment Responses Suggesting Suitable Biological Effective Dose Formula for Single and 10 Fractions.
    Ohtakara K; Nakabayashi K; Suzuki K
    Cureus; 2023 Feb; 15(2):e34636. PubMed ID: 36895545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.
    Gay HA; Jin JY; Chang AJ; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
    Brenner DJ
    Semin Radiat Oncol; 2008 Oct; 18(4):234-9. PubMed ID: 18725109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma.
    Liu F; Brown DR; Munley MT
    Radiother Oncol; 2024 May; 194():110223. PubMed ID: 38467342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
    Zhang H; Zhong H; Barth RF; Cao M; Das IJ
    Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays.
    Herskind C; Wenz F
    Strahlenther Onkol; 2010 Aug; 186(8):444-51. PubMed ID: 20803285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model.
    Konradsson E; Liljedahl E; Gustafsson E; Adrian G; Beyer S; Ilaahi SE; Petersson K; Ceberg C; Nittby Redebrandt H
    Adv Radiat Oncol; 2022; 7(6):101011. PubMed ID: 36092986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
    Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FLASH radiotherapy sparing effect on the circulating lymphocytes in pencil beam scanning proton therapy: impact of hypofractionation and dose rate.
    Galts A; Hammi A
    Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38081067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.